ATP synthase inhibitor 1

ATP synthase inhibitor 1 Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 18916372613
Email: yanzihan@shyuanye.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com

ATP synthase inhibitor 1 manufacturers

ATP synthase inhibitor 1 Basic information
Product Name:ATP synthase inhibitor 1
Synonyms:ATP SYNTHASE INHIBITOR 1;ATP Synthase,ATP synthase inhibitor 1,Inhibitor,inhibit,ATP synthase inhibitor-1,ATP synthase inhibitor1;1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(5-chloro-2-thienyl)sulfonyl]-1-phenyl-;8-((5-Chlorothiophen-2-yl)sulfonyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
CAS:1023043-30-2
MF:C17H18ClN3O3S2
MW:411.93
EINECS:
Product Categories:
Mol File:1023043-30-2.mol
ATP synthase inhibitor 1 Structure
ATP synthase inhibitor 1 Chemical Properties
density 1.55±0.1 g/cm3(Predicted)
storage temp. Store at -20°C,unstable in solution, ready to use.
solubility DMSO: 5 mg/mL (12.14 mM)
pka14.80±0.20(Predicted)
form Solid
color Off-white to light yellow
Safety Information
MSDS Information
ATP synthase inhibitor 1 Usage And Synthesis
Description

ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels[1]. F1/FO-ATP synthase[1]

ATP synthase inhibitor 1 (Compound 10) is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex[1].

UsesATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels[1].
References

[1]. Morciano G, et al. Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. J Med Chem. 2018 Aug 23;61(16):7131-7143.

ATP synthase inhibitor 1 Preparation Products And Raw materials
Tag:ATP synthase inhibitor 1(1023043-30-2) Related Product Information
[1-(5-chlorothiophen-2-yl)sulfonylpiperidin-2-yl]-pyrrolidin-1-ylmethanone 3-methyl-8-thiophen-2-ylsulfonyl-1,3,8-triazaspiro[4.5]decane-2,4-dione ATP synthase inhibitor 1 1,3,8-Triazaspiro[4.5]decane-2,4-dione, 3-ethyl-8-(2-thienylsulfonyl)- Cyclocreatine 3-(beta-D-Galactopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium chloride